Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1036020230120030237
ÁöÁú.µ¿¸Æ°æÈ­ÇÐȸÁö
2023 Volume.12 No. 3 p.237 ~ p.251
Dyslipidemia Fact Sheet in Korea, 2022
Jin Eun-Sun

Shim Jee-Seon
Kim Sung-Eun
Bae Jae-Hyun
Kang Shin-Ae
Won Jong-Chul
Shin Min-Jeong
Jin Heung-Yong
Moon Jenny
Lee Ho-Kyou
Kim Hyeon-Chang
Jeong In-Kyung
Abstract
Objective : This study aimed to investigate the prevalence and status of dyslipidemia management among South Korean adults, as performed by the Korean Society of Lipid and Atherosclerosis under the name Dyslipidemia Fact Sheet 2022.

Methods : We analyzed the lipid profiles, age-standardized and crude prevalence, management status of hypercholesterolemia and dyslipidemia, and health behaviors among Korean adults aged ¡Ã20 years, using the Korea National Health and Nutrition Examination Survey data between 2007 and 2020.

Results : In South Korea, the crude prevalence of hypercholesterolemia (total cholesterol ¡Ã240 mg/dL or use of a lipid-lowering drug) in 2020 was 24%, and the age-standardized prevalence of hypercholesterolemia more than doubled from 2007 to 2020. The crude treatment rate was 55.2%, and the control rate was 47.7%. The crude prevalence of dyslipidemia (more than one out of three conditions [low-density lipoprotein-cholesterol ¡Ã160 or the use of a lipid-lowering drug, triglycerides ¡Ã200, or high-density lipoprotein-cholesterol (men and women) <40 mg/dL]) was 40.2% between 2016 and 2020. However, it increased to 48.2% when the definition of hypo-high-density lipoprotein-cholesterolemia in women changed from <40 to <50 mg/dL.

Conclusion : Although the prevalence of hypercholesterolemia and dyslipidemia has steadily increased in South Korea, the treatment rate remains low. Therefore, continuous efforts are needed to manage dyslipidemia through cooperation between the national healthcare system, patients, and healthcare providers.
KEYWORD
Dyslipidemias, Cholesterol, Prevalence, Disease management, Health behavior, Republic of Korea
FullTexts / Linksout information
Listed journal information